Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of the Upcoming October 3rd Deadline in the Class Action Law...
September 22 2016 - 01:07PM
Business Wire
Investors with losses of $50,000 or more are encouraged to
contact the firm to discuss their legal rights.
Law Offices of Howard G. Smith reminds investors of the
upcoming October 3, 2016 deadline to file a lead
plaintiff motion in the class action filed on behalf of a class
(the “Class”) of investors who purchased or otherwise acquired
Keryx Pharmaceuticals, Inc. ("Keryx" or the "Company") (NASDAQ:
KERX) securities between September 2, 2013, and August 1,
2016, inclusive (the “Class Period”). Keryx investors have
October 3, 2016 to file a lead plaintiff motion.
The complaint filed in this lawsuit alleges that
throughout the Class Period, Defendants made materially false
and/or misleading statements, and/or failed to disclose: (1) that
the Company was experiencing production-related difficulties in
converting API to finished drug product; (2) that the issue was
resulting in decreased production yields of finished drug product;
(3) that, as a result, the Company would, and did exhaust its
reserve of finished drug product; and (4) that, as a result of the
foregoing, Defendants’ statements about Keryx’s business,
operations, and prospects, were false and misleading and/or lacked
a reasonable basis.
If you purchased Keryx shares, you may move the Court no later
than October 3, 2016 to request appointment as
lead plaintiff. To be a member of the class you need not take any
action at this time; you may retain counsel of your choice or take
no action and remain an absent member of the Class. If you wish
to learn more about this action, or if you have any
questions concerning this announcement or your rights or interests
with respect to these matters, please contact Howard G. Smith,
Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike,
Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215)
638-4847, toll-free at (888) 638-4847, or by email
to howardsmith@howardsmithlaw.com, or visit our website
at http://www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160922006110/en/
Law Offices of Howard G. SmithHoward G. Smith,
Esquire215-638-4847888-638-4847howardsmith@howardsmithlaw.comwww.howardsmithlaw.com
Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Historical Stock Chart
From Feb 2024 to Mar 2024
Keryx Biopharmaceuticals, Inc. (delisted) (NASDAQ:KERX)
Historical Stock Chart
From Mar 2023 to Mar 2024